Literature DB >> 32553720

Inoculum at the time of SARS-CoV-2 exposure and risk of disease severity.

María Pilar Guallar1, Rosa Meiriño2, Carolina Donat-Vargas3, Octavio Corral4, Nicolás Jouvé4, Vicente Soriano5.   

Abstract

A relationship between the infecting dose and the risk of disease severity has not been demonstrated for SARS-CoV-2 infection. Here, we report three clusters of individuals that were potentially exposed to distinct inoculum in Madrid. Overall each group developed divergent clinical forms of COVID-19. Our data support that a greater viral inoculum at the time of SARS-CoV-2 exposure might determine a higher risk of severe COVID-19.
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  COVID-19; coronavirus; disease severity; epidemiology; inoculum; outbreak; transmission

Mesh:

Year:  2020        PMID: 32553720      PMCID: PMC7293836          DOI: 10.1016/j.ijid.2020.06.035

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


A relationship between the infecting dose and the risk of disease severity has been demonstrated for several viral infections, including influenza and SARS (Hijano et al., 2019, Chu et al., 2004). For COVID-19, high viral loads either in saliva, respiratory secretions, or blood have been associated with more severe illness (Xu et al., 2020, To et al., 2020). However, it remains unclear whether exposure to a greater viral inoculum could determine a higher risk for developing severe COVID-19. Although intuitive, it has been challenging to obtain such dose-response data. Herein we report three clusters of SARS-CoV-2 infection in Madrid, in which infected persons experienced divergent clinical outcomes, namely severe, mild, or asymptomatic. We hypothesize that distinct sizes of viral inoculum at the time of exposure could explain their different illness course. The first cluster was represented by 25 women (age range, 34 to 86 years-old) that lived in a community located on the outskirts of Madrid. The house was large (2000 m2), with three floors, spacious typical ballrooms and halls, high ceilings, large rooms, and a big garden (1500 m2). Lockdown with strict stay home confinement was declared in Madrid on March 14. The day before, the index case, a 47-year-old woman was shopping and visiting relatives. On March 16, she developed fever, cough, anosmia, and dysgeusia. Despite isolation at her room, two household members developed mild symptoms 2-3 days later and another 15 during the following two weeks. Antibody tests performed on April 28 to all 25 residents identified three additional infected asymptomatic persons, whereas four remained seronegative (Fig. 1 ). In this cluster, low viral exposures and social distancing would account for more benign clinical forms of COVID-19, along with asymptomatic and uninfected cases.
Fig. 1

The timeframe of SARS-CoV-2 infections and COVID-19 disease severity in persons belonging to groups with different viral exposure.

The timeframe of SARS-CoV-2 infections and COVID-19 disease severity in persons belonging to groups with different viral exposure. A second cluster of COVID-19 was identified in a group of 12 women (age range, 53 to 85 years-old) that lived together in an apartment flat (650 m2) in downtown Madrid. Several of them admitted going outside their home multiple times despite lockdown implementation. Furthermore, many acknowledged poor compliance with social distancing measures. Therefore, more than one index case could be expected in this site. From March 21th to 23rd, six of them developed mild to severe COVID-19 symptoms and asked for medical assessment at home or nearby clinics. Three developed bilateral pneumonia, one being hospitalized and requiring intensive care support. From March 25 to April 3, another four developed mild to severe symptoms, with one being hospitalized with bilateral pneumonia. Antibody tests on April 28 confirmed infection in all 12 residents, including two that had remained asymptomatic. In this cluster, indoor continuous viral exposure could account for a broader presentation of clinical forms of COVID-19, given that all residents were infected. The third cluster consisted of a group of ten adults (seven male; age range, 56 to 76 years-old) that met in a small conference room (60 m2) for three hours on March 4, ten days before the nationwide lockdown was implemented. The event was held at a health institution in downtown Madrid. Three attendees had just arrived from Rome (two) and Milan (one), where they had been for a few days. All attendees were asymptomatic on the meeting day and did not take any preventive measures, including sitting next to each other and not wearing face masks. Two days later, two developed COVID-19 symptoms and the rest also did within the next week. COVID-19 was severe in at least four individuals, one being hospitalized at the intensive care unit for nearly one month. Fortunately, he recovered. This cluster reminds one of many features of a large outbreak reported among members of a choir in Washington, USA (Hamner et al., 2020). In this cluster, an extensive indoor viral exposure seemed to account for all attendees' infection and the development of severe clinical forms in half of them. It is worth noting that of the six major determinants of SARS-CoV-2 susceptibility to infection and risk for disease severity (Fig. 2 ), the first two clusters only included women, whereas seven out of ten in the last cluster were male. The mean ages (63.4, 66.3, 62.7 years old, respectively) and the rate of chronic co-morbidities (roughly two-thirds of each group, with hypertension the most common) did not differ significantly in comparing the three clusters. Information on potential cross-immunity with other endemic coronaviruses or genetic variants that could influence the SARS-CoV-2 disease course, was not available, but all individuals were living in Madrid and were Caucasian. Therefore, we hypothesize that a different inoculum at the time of SARS-CoV-2 exposure could explain the different course of infection in these three clusters.
Fig. 2

Major determinants of SARS-CoV-2 susceptibility to infection and risk for disease severity.

Major determinants of SARS-CoV-2 susceptibility to infection and risk for disease severity. Intriguingly, most recent SARS-CoV-2 infections seem to be less virulent than those that occurred earlier in the COVID-19 outbreak (Pan et al., 2020, Little et al., 2020). Several factors might contribute to this observation, including more frequent late presentations at the beginning of the pandemic. Alternatively, the new coronavirus could steadily become less pathogenic, as result of co-adaptation to human hosts (Martinez, 2020). However, our findings suggest that it most likely reflects the overall lower size of the inoculum in recent infections due to extensive social distancing interventions compared to contagions that occurred earlier in the pandemic. The recognition that exposure to low viral loads is associated with mild or asymptomatic infections would favor a sensible gradual re-opening of activities. For instance, restricting indoor gatherings where superspreading events are more likely to occur will have a significant impact on transmission, whereas other restrictions —on outdoor activity, for example— might be eased. Promoting activities in open spaces, coupled with rapid isolation of symptomatic persons (self-confinement) and quarantine of contacts would act synergistically to halt COVID-19 spread and severity (Cowling et al., 2020). Since overall 80% of the contagions seem to have derived from only 10% of infected individuals (Jarvis et al., 2020), shifting the SARS-CoV-2 community transmission rate (R0) to less than 2 would require that less than half of the population would need to be infected to produce herd immunity (Fig. 3 ). In this scenario, COVID-19 spreading would be expected to be controlled, even in the absence of antivirals or vaccines. Our data support the proposal that keeping social distancing would be effective in reducing contagions as well as driving COVID-19 to less severe forms. This information is crucial when re-opening strategies are urgently needed to alleviate the harmful economic impact of prolonged lockdowns.
Fig. 3

Herd immunity needed to halt the COVID-19 pandemic as a function of the average community transmission rate (R0).

Herd immunity needed to halt the COVID-19 pandemic as a function of the average community transmission rate (R0).

Conflict of Interests

None.

Funding

We would like to thank the UNIR Foundation for funding diagnostic tests for SARS-CoV-2 antibody detection.

Ethical approval

The study received approval as a descriptive and retrospective observational analysis.
  42 in total

1.  Exposing and Overcoming Limitations of Clinical Laboratory Tests in COVID-19 by Adding Immunological Parameters; A Retrospective Cohort Analysis and Pilot Study.

Authors:  Adrián Sánchez-Montalvá; Daniel Álvarez-Sierra; Mónica Martínez-Gallo; Janire Perurena-Prieto; Iria Arrese-Muñoz; Juan Carlos Ruiz-Rodríguez; Juan Espinosa-Pereiro; Pau Bosch-Nicolau; Xavier Martínez-Gómez; Andrés Antón; Ferran Martínez-Valle; Mar Riveiro-Barciela; Albert Blanco-Grau; Francisco Rodríguez-Frias; Pol Castellano-Escuder; Elisabet Poyatos-Canton; Jordi Bas-Minguet; Eva Martínez-Cáceres; Alex Sánchez-Pla; Coral Zurera-Egea; Aina Teniente-Serra; Manuel Hernández-González; Ricardo Pujol-Borrell
Journal:  Front Immunol       Date:  2022-06-29       Impact factor: 8.786

2.  Face masking and COVID-19: potential effects of variolation on transmission dynamics.

Authors:  Zachary Levine; David J D Earn
Journal:  J R Soc Interface       Date:  2022-05-04       Impact factor: 4.293

3.  Major Spinal Surgery Between Two Documented COVID-19 Infections in an Elderly Female: A Case Report.

Authors:  Bishruti Sharma; Nabin Paudyal; Binod Rajbhandari; Amit Pradhanang; Nikita Dwa; Ajay Pradhan; Mohan Raj Sharma
Journal:  JNMA J Nepal Med Assoc       Date:  2021-10-15       Impact factor: 0.556

Review 4.  Breathing, speaking, coughing or sneezing: What drives transmission of SARS-CoV-2?

Authors:  V Stadnytskyi; P Anfinrud; A Bax
Journal:  J Intern Med       Date:  2021-06-08       Impact factor: 13.068

5.  Risk-mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey.

Authors:  S K Mahil; M Yates; S M Langan; Z Z N Yiu; T Tsakok; N Dand; K J Mason; H McAteer; F Meynell; B Coker; A Vincent; D Urmston; A Vesty; J Kelly; C Lancelot; L Moorhead; H Bachelez; I N Bruce; F Capon; C R Contreras; A P Cope; C De La Cruz; P Di Meglio; P Gisondi; K Hyrich; D Jullien; J Lambert; H Marzo-Ortega; I McInnes; L Naldi; S Norton; L Puig; R Sengupta; P Spuls; T Torres; R B Warren; H Waweru; J Weinman; C E M Griffiths; J N Barker; M A Brown; J B Galloway; C H Smith
Journal:  Br J Dermatol       Date:  2021-03-09       Impact factor: 11.113

6.  Will SARS-CoV-2 Become Just Another Seasonal Coronavirus?

Authors:  Alexander B Beams; Rebecca Bateman; Frederick R Adler
Journal:  Viruses       Date:  2021-05-07       Impact factor: 5.048

7.  Fatal SARS-CoV-2 reinfection in an immunosuppressed patient on hemodialysis.

Authors:  Diana Rodríguez-Espinosa; José Jesús Broseta Monzó; Quim Casals; Gastón J Piñeiro; Lida Rodas; Manel Vera; Francisco Maduell
Journal:  J Nephrol       Date:  2021-06-07       Impact factor: 3.902

Review 8.  COVID-19: a review of current knowledge regarding exposure, quarantine, isolation and other preventive measures.

Authors:  Robert Rosolanka; Andres F Henao-Martinez; Larissa Pisney; Carlos Franco-Paredes; Martin Krsak
Journal:  Ther Adv Infect Dis       Date:  2021-07-14

9.  Centrality of G6PD in COVID-19: The Biochemical Rationale and Clinical Implications.

Authors:  Yuliya Buinitskaya; Roman Gurinovich; Clifford G Wlodaver; Siarhei Kastsiuchenka
Journal:  Front Med (Lausanne)       Date:  2020-10-22

10.  Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.

Authors:  Marta Massanella; Anabel Martin-Urda; Lourdes Mateu; Toni Marín; Irene Aldas; Eva Riveira-Muñoz; Athina Kipelainen; Esther Jiménez-Moyano; Maria Luisa Rodriguez de la Concepción; Carlos Avila-Nieto; Benjamin Trinité; Edwards Pradenas; Jordi Rodon; Silvia Marfil; Mariona Parera; Jorge Carrillo; Julià Blanco; Julia G Prado; Ester Ballana; Júlia Vergara-Alert; Joaquim Segalés; Marc Noguera-Julian; Àngels Masabeu; Bonaventura Clotet; Maria de la Roca Toda; Roger Paredes
Journal:  Open Forum Infect Dis       Date:  2021-06-23       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.